Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 04:00PM ET
13.89
Dollar change
+0.40
Percentage change
2.97
%
IndexRUT P/E- EPS (ttm)-3.25 Insider Own20.93% Shs Outstand32.42M Perf Week-0.71%
Market Cap450.31M Forward P/E- EPS next Y-2.86 Insider Trans60.18% Shs Float25.63M Perf Month21.95%
Income-80.33M PEG- EPS next Q-0.76 Inst Own70.02% Short Float1.76% Perf Quarter1.76%
Sales0.00M P/S- EPS this Y10.60% Inst Trans-0.43% Short Ratio5.46 Perf Half Y247.25%
Book/sh5.53 P/B2.51 EPS next Y3.17% ROA-39.37% Short Interest0.45M Perf Year-3.27%
Cash/sh5.40 P/C2.57 EPS next 5Y- ROE-46.72% 52W Range3.72 - 17.51 Perf YTD104.26%
Dividend Est.- P/FCF- EPS past 5Y-172.30% ROI-41.04% 52W High-20.67% Beta1.63
Dividend TTM- Quick Ratio15.78 Sales past 5Y0.00% Gross Margin- 52W Low273.39% ATR (14)1.05
Dividend Ex-Date- Current Ratio15.78 EPS Y/Y TTM2.65% Oper. Margin0.00% RSI (14)54.98 Volatility7.10% 7.75%
Employees64 Debt/Eq0.11 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price21.60
Option/ShortNo / Yes LT Debt/Eq0.09 EPS Q/Q8.44% Payout- Rel Volume2.44 Prev Close13.49
Sales Surprise- EPS Surprise18.85% Sales Q/Q- EarningsMay 14 AMC Avg Volume82.59K Price13.89
SMA205.19% SMA505.76% SMA20058.20% Trades Volume201,602 Change2.97%
Date Action Analyst Rating Change Price Target Change
Dec-21-22Initiated H.C. Wainwright Buy $26
May-15-24 01:20PM
May-14-24 10:55PM
04:02PM
Apr-12-24 01:30PM
Mar-13-24 04:05PM
07:00AM Loading…
07:00AM
Mar-12-24 09:55AM
Mar-11-24 12:00PM
Mar-06-24 11:54PM
04:01PM
Mar-04-24 07:00AM
Feb-29-24 03:02AM
Feb-20-24 08:00AM
Feb-07-24 07:30AM
Jan-17-24 07:00AM
07:00AM Loading…
Jan-08-24 07:00AM
Dec-18-23 08:00AM
Nov-15-23 08:00AM
Nov-08-23 08:00AM
Oct-12-23 07:00AM
Sep-27-23 04:16PM
Sep-06-23 04:05PM
08:00AM
Sep-01-23 08:00AM
Aug-08-23 08:15AM
Jun-13-23 04:05PM
May-31-23 11:44AM
May-30-23 04:05PM
May-18-23 07:00AM
May-11-23 07:00AM
08:00AM Loading…
May-04-23 08:00AM
Apr-17-23 08:00AM
Apr-13-23 04:05PM
Mar-27-23 02:25AM
Mar-23-23 04:05PM
Mar-22-23 08:00AM
Mar-21-23 04:05PM
Mar-16-23 08:00AM
Mar-13-23 08:00AM
Feb-27-23 08:50AM
Feb-09-23 08:00AM
Jan-31-23 08:50AM
Jan-16-23 05:10AM
Jan-13-23 08:50AM
Dec-21-22 02:25PM
Dec-07-22 08:00AM
Dec-01-22 09:55AM
Nov-21-22 08:50AM
Nov-15-22 09:55AM
Nov-14-22 08:00AM
Nov-10-22 08:00AM
Nov-08-22 08:00AM
Oct-13-22 01:00PM
Sep-28-22 01:59PM
09:25AM
06:00AM
Sep-22-22 08:00AM
Sep-04-22 07:17AM
Aug-12-22 08:00AM
Aug-08-22 10:51AM
Jul-22-22 07:45AM
Jun-16-22 08:30AM
May-27-22 05:22PM
May-05-22 11:34PM
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Svenstrup NielsSVP, Chem. Mfg & ControlsMay 17 '24Sale13.4110,000134,1000May 17 08:51 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 09 '24Buy10.642,557,59327,212,7909,179,273Feb 13 04:33 PM
McArthur James GPresident and CEONov 30 '23Buy4.171,6947,0561,694Dec 05 07:34 AM
McArthur James GPresident and CEOJun 08 '23Option Exercise2.712,3816,4532,381Jun 09 07:06 PM
McArthur James GPresident and CEOJun 08 '23Sale16.042,38138,1880Jun 09 07:06 PM
McArthur James GPresident and CEOJun 07 '23Option Exercise2.718,41922,8158,419Jun 08 05:23 PM
McArthur James GPresident and CEOJun 07 '23Sale16.238,419136,6180Jun 08 05:23 PM
McArthur James GPresident and CEOJun 06 '23Option Exercise2.7118,15049,18618,150Jun 08 05:23 PM
McArthur James GPresident and CEOJun 06 '23Sale16.1818,150293,6600Jun 08 05:23 PM
McArthur James GPresident and CEOJun 05 '23Option Exercise2.715001,355500Jun 06 04:19 PM
McArthur James GPresident and CEOJun 05 '23Sale16.065008,0280Jun 06 04:19 PM
McArthur James GPresident and CEOJun 02 '23Option Exercise2.711,8004,8781,800Jun 06 04:19 PM
McArthur James GPresident and CEOJun 02 '23Sale16.041,80028,8630Jun 06 04:19 PM